{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:10:19Z","timestamp":1789193419084,"version":"build-2803163510"},"reference-count":34,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"unspecified","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K18440"],"award-info":[{"award-number":["22K18440"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23H00551"],"award-info":[{"award-number":["23H00551"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025019","name":"Support for Pioneering Research Initiated by the Next Generation","doi-asserted-by":"publisher","award":["JPMJSP2102"],"award-info":[{"award-number":["JPMJSP2102"]}],"id":[{"id":"10.13039\/501100025019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJSF2318"],"award-info":[{"award-number":["JPMJSF2318"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2025,10,29]]},"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite remarkable advances in cancer immunotherapy, including immune checkpoint inhibitors and adoptive cell therapies, many patients fail to achieve durable responses due to factors such as immunosuppressive tumor microenvironments, poor tumor antigenicity, and systemic toxicity. These limitations underscore the need for alternative platforms that can elicit robust and localized antitumor immune responses. Bacteria have emerged as promising candidates owing to their natural ability to selectively colonize tumors, stimulate innate and adaptive immunity, and be engineered for therapeutic delivery. However, the therapeutic potential of naturally occurring marine bacterial strains remains largely unexplored in colorectal cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We screened a panel of marine bacterial strains for antitumor activity in syngeneic and orthotopic mouse models of colorectal cancer.\n                      <jats:italic>Photobacterium angustum<\/jats:italic>\n                      was selected based on its potent antitumor effects. We evaluated tumor colonization, systemic toxicity, and immune responses following intravenous administration. Biosafety was assessed via serum cytokine profiling and hematological analysis. Immune activation was examined by quantitative PCR and immunohistochemistry.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>P. angustum<\/jats:italic>\n                      therapy significantly prolonged survival in tumor-bearing mice and exhibited strong tumor tropism with minimal colonization of healthy tissues. Systemic administration was well tolerated, with low levels of pro-inflammatory cytokines and no hematological toxicity. Treatment enhanced infiltration of T cells, B cells, and neutrophils in the tumor microenvironment, accompanied by elevated intratumoral tumor necrosis factor-\u03b1 and interferon-\u03b3 levels. Additionally,\n                      <jats:italic>P. angustum<\/jats:italic>\n                      demonstrated intrinsic oncolytic activity, contributing to direct tumor cell lysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our findings support\n                      <jats:italic>P. angustum<\/jats:italic>\n                      as a promising platform for bacterial immunotherapy in colorectal cancer, combining tumor-specific colonization, immune activation, and direct tumoricidal effects with an excellent safety profile.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2025-012665","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:40:12Z","timestamp":1763574012000},"page":"e012665","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic administration of\n                    <i>Photobacterium angustum<\/i>\n                    promotes antitumor immunity and direct tumor lysis in murine models of colorectal cancer"],"prefix":"10.1136","volume":"13","author":[{"given":"Mikako","family":"Miyahara","sequence":"first","affiliation":[{"name":"Graduate School of Advanced Science and Technology, Japan Advanced Institute of Science and Technology, Nomi, Ishikawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhisa","family":"Takizawa","sequence":"additional","affiliation":[{"name":"Graduate School of Advanced Science and Technology, Japan Advanced Institute of Science and Technology, Nomi, Ishikawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matomo","family":"Sakari","sequence":"additional","affiliation":[{"name":"Graduate School of Advanced Science and Technology, Japan Advanced Institute of Science and Technology, Nomi, Ishikawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1157-6174","authenticated-orcid":false,"given":"Eijiro","family":"Miyako","sequence":"additional","affiliation":[{"name":"Graduate School of Advanced Science and Technology, Japan Advanced Institute of Science and Technology, Nomi, Ishikawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"2026091123003837000_13.11.e012665.1","doi-asserted-by":"crossref","unstructured":"Hoffman RM , ed. Bacterial therapy of cancer: methods and protocols. Netherlands: Humana Press, Springer, 2015.","DOI":"10.1007\/978-1-4939-3515-4_15"},{"key":"2026091123003837000_13.11.e012665.2","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1026248","article-title":"Recent advances in bacteria-mediated cancer therapy","volume":"10","author":"Liang","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"2026091123003837000_13.11.e012665.3","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1002\/cam4.4799","article-title":"Bacteria in cancer therapy: A new generation of weapons","volume":"11","author":"Fan","year":"2022","journal-title":"Cancer Med"},{"key":"2026091123003837000_13.11.e012665.4","doi-asserted-by":"crossref","unstructured":"Iwata S , Nishiyama T , Sakari M , et al . Tumour-resident oncolytic bacteria trigger potent anticancer effects through selective intratumoural thrombosis and necrosis. Nat Biomed Eng 2025;in. doi:10.1038\/s41551-025-01459-9","DOI":"10.1038\/s41551-025-01459-9"},{"key":"2026091123003837000_13.11.e012665.5","doi-asserted-by":"crossref","first-page":"100193","DOI":"10.1016\/j.celbio.2025.100193","article-title":"Living drugs: A wonderful evolution for therapeutic applications","volume":"in","author":"Chintalapati","year":"2025","journal-title":"Cell Biomaterials"},{"key":"2026091123003837000_13.11.e012665.6","doi-asserted-by":"crossref","first-page":"156378","DOI":"10.1016\/j.cej.2024.156378","article-title":"Photocatalytic scaffolds enhance anticancer performances of bacterial consortium AUN","volume":"499","author":"Miyahara","year":"2024","journal-title":"Chem Eng J"},{"key":"2026091123003837000_13.11.e012665.7","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301679","article-title":"Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics","volume":"10","author":"Goto","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"2026091123003837000_13.11.e012665.8","doi-asserted-by":"crossref","first-page":"116041","DOI":"10.1016\/j.biopha.2023.116041","article-title":"Tumor-isolated Cutibacterium acnes as an effective tumor suppressive living drug","volume":"170","author":"Chintalapati","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"2026091123003837000_13.11.e012665.9","doi-asserted-by":"crossref","first-page":"2205641","DOI":"10.1002\/advs.202205641","article-title":"Bacterial\u2010Mediated Tumor Therapy: Old Treatment in a New Context","volume":"10","author":"Liu","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"2026091123003837000_13.11.e012665.10","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9121497","article-title":"Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy","volume":"9","author":"Gupta","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"2026091123003837000_13.11.e012665.11","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2934"},{"key":"2026091123003837000_13.11.e012665.12","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2023.0292"},{"key":"2026091123003837000_13.11.e012665.13","doi-asserted-by":"crossref","DOI":"10.1186\/1423-0127-17-21","article-title":"Bacteria in cancer therapy: a novel experimental strategy","volume":"17","author":"Patyar","year":"2010","journal-title":"J Biomed Sci"},{"key":"2026091123003837000_13.11.e012665.14","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2008.32"},{"key":"2026091123003837000_13.11.e012665.15","doi-asserted-by":"crossref","first-page":"121332","DOI":"10.1016\/j.biomaterials.2021.121332","article-title":"Engineering bioluminescent bacteria to boost photodynamic therapy and systemic anti-tumor immunity for synergistic cancer treatment","volume":"281","author":"Yang","year":"2022","journal-title":"Biomaterials"},{"key":"2026091123003837000_13.11.e012665.16","unstructured":"Type strains genome database. n.d. Available: https:\/\/gctype.wdcm.org\/"},{"key":"2026091123003837000_13.11.e012665.17","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00458-8"},{"key":"2026091123003837000_13.11.e012665.18","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106958","article-title":"Mouse models in colon cancer, inferences, and implications","volume":"26","author":"Kucherlapati","year":"2023","journal-title":"iScience"},{"key":"2026091123003837000_13.11.e012665.19","doi-asserted-by":"crossref","unstructured":"Bonetto A , Rupert JE , Barreto R , et al . The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia. J Vis Exp 2016.:54893. doi:10.3791\/54893","DOI":"10.3791\/54893-v"},{"key":"2026091123003837000_13.11.e012665.20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10585-016-9797-7","article-title":"Endoscopy-guided orthotopic implantation of colorectal cancer cells results in metastatic colorectal cancer in mice","volume":"33","author":"Bettenworth","year":"2016","journal-title":"Clin Exp Metastasis"},{"key":"2026091123003837000_13.11.e012665.21","doi-asserted-by":"crossref","DOI":"10.4103\/1477-3163.78279","article-title":"The AOM\/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies","volume":"10","author":"De Robertis","year":"2011","journal-title":"J Carcinog"},{"key":"2026091123003837000_13.11.e012665.22","doi-asserted-by":"publisher","DOI":"10.1038\/nri3345"},{"key":"2026091123003837000_13.11.e012665.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00552-1"},{"key":"2026091123003837000_13.11.e012665.24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194945","article-title":"Recent Advances in Bacteria-Based Cancer Treatment","volume":"14","author":"Wei","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026091123003837000_13.11.e012665.25","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/cam4.2148","article-title":"Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities","volume":"8","author":"Sedighi","year":"2019","journal-title":"Cancer Med"},{"key":"2026091123003837000_13.11.e012665.26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40487-021-00177-x","article-title":"Bacterial-Based Methods for Cancer Treatment: What We Know and Where We Are","volume":"10","author":"Rommasi","year":"2022","journal-title":"Oncol Ther"},{"key":"2026091123003837000_13.11.e012665.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2008.08.004"},{"key":"2026091123003837000_13.11.e012665.28","doi-asserted-by":"crossref","first-page":"104141","DOI":"10.1016\/j.critrevonc.2023.104141","article-title":"Bacteria-driven cancer therapy: Exploring advancements and challenges","volume":"191","author":"Din","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026091123003837000_13.11.e012665.29","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202105086","article-title":"Bacteria\u2010Elicited Specific Thrombosis Utilizing Acid\u2010Induced Cytolysin A Expression to Enable Potent Tumor Therapy","volume":"9","author":"Qin","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"2026091123003837000_13.11.e012665.30","doi-asserted-by":"publisher","DOI":"10.1111\/apha.12156"},{"key":"2026091123003837000_13.11.e012665.31","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-018-0196-9"},{"key":"2026091123003837000_13.11.e012665.32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006692","article-title":"Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha","volume":"4","author":"Leschner","year":"2009","journal-title":"PLoS One"},{"key":"2026091123003837000_13.11.e012665.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.09.010"},{"key":"2026091123003837000_13.11.e012665.34","article-title":"Neutrophil depletion enhanced the Clostridium novyi-NT therapy in mouse and rabbit tumor models","volume":"4","author":"Staedtke","year":"2022","journal-title":"Neurooncol Adv"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2025-012665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:00:51Z","timestamp":1789192851000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2025-012665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":34,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,19]]},"published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1136\/jitc-2025-012665"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2025-012665","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}